BRIEF published on 07/25/2024 at 22:03, 3 months 26 days ago Vitruvia Medical AG: Half-Year Results as of June 30, 2024 Financial Performance Half-year Results 2024 Forecast Sales Targets Vitruvia Medical AG
PRESS RELEASE published on 07/25/2024 at 21:58, 3 months 26 days ago EQS-Adhoc: Vitruvia Medical AG: Half yearly results as per June 30th, 2024 Vitruvia Medical AG reports half-year results in line with expectations for the first half of 2024, confirming full-year forecast. Positive outlook with expected sales around EUR 2.0 million Sales Forecast Earnings Half-year Results Vitruvia Medical AG
BRIEF published on 05/01/2024 at 08:41, 6 months 20 days ago Vitruvia Medical AG Announces Improved Year-End Financial Results for 2023 Financial Results Revenue Growth 2024 Outlook Vitruvia Medical AG EBITA Improvement
PRESS RELEASE published on 05/01/2024 at 08:36, 6 months 20 days ago EQS-Adhoc: Vitruvia Medical AG: Year End results as of December 31, 2023 Vitruvia Medical AG reports Year End results for 2023 with revenue and earnings growth. Financial performance overview and outlook for LT technologies for 2024 Revenue Growth Financial Performance Vitruvia Medical AG Year End Results LT Technologies
PRESS RELEASE published on 09/29/2023 at 13:15, 1 year 1 month ago Vitruvia Medical AG: Consolidated interim results as per June 30th,2023
PRESS RELEASE published on 09/29/2023 at 12:15, 1 year 1 month ago EQS-Adhoc: Vitruvia Medical AG: Consolidated interim results as per June 30th,2023
PRESS RELEASE published on 07/28/2023 at 08:17, 1 year 3 months ago Vitruvia Medical AG: Shareholders approved all proposals at the Annual General Meeting of Shareholders
PRESS RELEASE published on 06/25/2023 at 09:59, 1 year 4 months ago EQS-Adhoc: Vitruvia Medical AG: Annual results as of 31.12.2022 and outlook 2023
PRESS RELEASE published on 03/27/2023 at 11:34, 1 year 7 months ago EQS-Adhoc: Vitruvia Medical AG: auhtorised capital increase
PRESS RELEASE published on 01/19/2023 at 11:47, 1 year 10 months ago Vitruvia Medical AG: Cooperation with TRES MEDICO, Malaysia
Published on 11/21/2024 at 10:03, 40 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 43 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 43 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 8 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 18 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 13 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 38 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 40 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 43 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 43 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 3 hours 45 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 23 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 58 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 58 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
